These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

698 related items for PubMed ID: 16393430

  • 1. Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology.
    Touchon J, Bergman H, Bullock R, Rapatz G, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Jan; 22(1):49-59. PubMed ID: 16393430
    [Abstract] [Full Text] [Related]

  • 2. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R, Bergman H, Touchon J, Gambina G, He Y, Nagel J, Lane R.
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [Abstract] [Full Text] [Related]

  • 3. Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.
    Blesa R, Bullock R, He Y, Bergman H, Gambina G, Meyer J, Rapatz G, Nagel J, Lane R.
    Pharmacogenet Genomics; 2006 Nov; 16(11):771-4. PubMed ID: 17047484
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M, Fox C, Maidment I, McShane R.
    Cochrane Database Syst Rev; 2012 Mar 14; 2012(3):CD006504. PubMed ID: 22419314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Donepezil for dementia due to Alzheimer's disease.
    Birks JS, Harvey RJ.
    Cochrane Database Syst Rev; 2018 Jun 18; 6(6):CD001190. PubMed ID: 29923184
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 18; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 10. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.
    Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y.
    Clin Ther; 2002 Jun 18; 24(6):862-86; discussion 837. PubMed ID: 12117079
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cholinesterase inhibitors for Alzheimer's disease.
    Birks J.
    Cochrane Database Syst Rev; 2006 Jan 25; 2006(1):CD005593. PubMed ID: 16437532
    [Abstract] [Full Text] [Related]

  • 14. Cholinesterase inhibitors for dementia with Lewy bodies.
    Wild R, Pettit T, Burns A.
    Cochrane Database Syst Rev; 2003 Jan 25; 2003(3):CD003672. PubMed ID: 12917981
    [Abstract] [Full Text] [Related]

  • 15. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study.
    Winblad B, Kilander L, Eriksson S, Minthon L, Båtsman S, Wetterholm AL, Jansson-Blixt C, Haglund A, Severe Alzheimer's Disease Study Group.
    Lancet; 2006 Apr 01; 367(9516):1057-1065. PubMed ID: 16581404
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
    Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A.
    Clin Ther; 2010 Jul 01; 32(7):1234-51. PubMed ID: 20678673
    [Abstract] [Full Text] [Related]

  • 17. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.
    Health Technol Assess; 2012 Jul 01; 16(21):1-470. PubMed ID: 22541366
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
    Chianella C, Gragnaniello D, Maisano Delser P, Visentini MF, Sette E, Tola MR, Barbujani G, Fuselli S.
    Eur J Clin Pharmacol; 2011 Nov 01; 67(11):1147-57. PubMed ID: 21630031
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.